Illuminate and Medexprim announce partnership to provide US and EU hospital researchers unprecedented insights into massive text report and medical image databases

Overland Park, KS US-based Softek Illuminate and the entrepreneurial French firm Medexprim announced today they will be combining, distributing and supporting each other’s product offerings as a unified solution for hospital researchers interested in exploiting previously unstructured clinical and image databases. The two companies will be featuring the other’s solutions at the Society for Imaging Informatics in Medicine (SIIM) Annual Meeting in National Harbour, Maryland, May 31- June 2 at their respective booths (Illuminate – #423; Medexprim -#104).

Illuminate provides its innovative InSight™ and PatientView™ solutions with a single purpose in mind: Assist radiology practices to unlock the value of patient records stored across multiple siloes of data to instantly deliver actionable intelligence.

Medexprim’s Radiomics Enabler® is an Extract/Transform/Load (ETL) solution that automates the selection, extraction, pseudonymization/de-identification and secured routing of larger numbers of image sequences from a PACS for secondary use in research.

“With the exponential growth of radiomics and machine learning in radiology, we needed to enrich our text mining suite with image extraction capabilities” says Matt McLenon, CEO of Softek Illuminate. “Medexprim’s suite allows us to provide these new services to our existing and future clients and expand our footprint in Europe.”

“Illuminate’s installed base is comprised of major, mostly U.S., research hospitals that are very active in artificial intelligence projects in medical imaging,” says Karine Seymour, Medexprim CEO. “They will now be able to easily access our technology thanks to the commercial and technical support of Illuminate. Additionally, Illuminate’s solutions complement our software by eliminating our customer’s challenge of mining through massive amounts of data to find the cohort of patients they wish to study.”

The combined solutions from Illuminate and Medexprim allow researchers to instantly create patient groups through unprecedented data-mining of unstructured data from a variety of systems (EMR, RIS, LIS), extract corresponding reports and imaging exams, curate and pseudonymize the results. The cleansed contextualized data can then be accessed by data scientists and other researchers interested in finding correlations between imaging features and other phenotypes and/or genotypes, as well as developing training data sets for machine learning algorithms.

Researchers will also be able to streamline the process of collecting data in clinical trials involving medical imaging, with faster, more qualitative results. Alerts on new events on a cohort of patients configured by Illuminate automatically triggers the extraction of corresponding imaging exams, while automated quality & control and pseudonymization is supplied by the Medexprim solution.

 

About Illuminate

Softek Illuminate (www.goilluminate.com) is a U.S. company providing solutions to help radiologists, pathologists, and academia improve science, patient care and business practices. Illuminate “puts EMR data to work” for the radiology practice and serves over 40 leading U.S. medical institutions, as well as customers in France, Australia and the Middle East.

Contact: Matt McLenon, CEO,  913.238.4096, matt.mcLenon@goilluminate.com

About Medexprim

Medexprim (www.medexprim.com) is a French company offering IT solutions to support healthcare institutions in the efficient and secure exploitation of their imaging exams and associated data, for research and big data projects, and in the valorization of these resources in external collaborations. Medexprim’s Radiomics Enabler® solution won the 2016 President’s Startup Challenge from the Pistoia Alliance and is a semi-finalist at the Society for Imaging Informatics in Medicine (SIIM) Innovation Challenge.

Contact: Karine Seymour, CEO, +33 777 257 889, kseymour@medexprim.com

 

Leave a Reply

Your email address will not be published. Required fields are marked *